NBC Securities’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.31K Buy
+150
New +$4.78K ﹤0.01% 2020
2025
Q3
Sell
-1,000
Closed -$24K 2777
2025
Q2
$24K Sell
1,000
-375
-27% -$8.22K ﹤0.01% 1626
2025
Q1
$28K Buy
1,375
+1,374
+137,400% +$34.5K ﹤0.01% 1345
2024
Q4
$32 Sell
1
-1,624
-100% -$40K ﹤0.01% 1102
2024
Q3
$41K Hold
1,625
﹤0.01% 1230
2024
Q2
$38K Hold
1,625
﹤0.01% 1218
2024
Q1
$46K Sell
1,625
-1,900
-54% -$57.1K ﹤0.01% 1155
2023
Q4
$115K Buy
3,525
+423
+14% +$11.5K 0.01% 902
2023
Q3
$86K Buy
+3,102
New +$101K 0.01% 980

Other funds holding ARKG

NBC Securities's ARKG Position: Q2 2026 in Review

NBC Securities opened a new position in ARK Genomic Revolution ETF (ARKG) in Q2 2026: 150 shares worth $6.31K. The stake represents ﹤0.01% of the portfolio and ranks #2020 among its holdings. This is a return to the name: NBC Securities previously reported a position in ARKG as recently as Q2 2025.

NBC Securities first reported a position in ARKG in Q3 2023 and has held it in 9 quarters since. The position peaked at $115K in Q4 2023. 272 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

  • NBC Securities held 150 shares of ARK Genomic Revolution ETF worth $6.31K as of Q2 2026.
  • ARK Genomic Revolution ETF was a new NBC Securities position in Q2 2026.
  • ARK Genomic Revolution ETF made up ﹤0.01% of NBC Securities's portfolio in Q2 2026, its #2020 holding.
  • NBC Securities first reported a position in ARK Genomic Revolution ETF in Q3 2023 and has held it in 9 quarters since.
  • NBC Securities's ARK Genomic Revolution ETF position peaked at $115K in Q4 2023.
  • 272 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on NBC Securities's 13F filing for Q2 2026, filed 21 Jul 2026.